Daniel Mrak

829 total citations
16 papers, 284 citations indexed

About

Daniel Mrak is a scholar working on Infectious Diseases, Epidemiology and Rheumatology. According to data from OpenAlex, Daniel Mrak has authored 16 papers receiving a total of 284 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Infectious Diseases, 6 papers in Epidemiology and 6 papers in Rheumatology. Recurrent topics in Daniel Mrak's work include SARS-CoV-2 and COVID-19 Research (6 papers), Peripheral Neuropathies and Disorders (4 papers) and Lipoproteins and Cardiovascular Health (3 papers). Daniel Mrak is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (6 papers), Peripheral Neuropathies and Disorders (4 papers) and Lipoproteins and Cardiovascular Health (3 papers). Daniel Mrak collaborates with scholars based in Austria and Egypt. Daniel Mrak's co-authors include Daniel Aletaha, Helga Radner, Michael Bonelli, Thomas Perkmann, Selma Tobudic, Stefan Winkler, Stephan Blüml, Helmuth Haslacher, Philipp Hofer and Karin Stiasny and has published in prestigious journals such as Frontiers in Immunology, Annals of the Rheumatic Diseases and Atherosclerosis.

In The Last Decade

Daniel Mrak

13 papers receiving 282 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel Mrak Austria 8 162 80 71 59 58 16 284
Jennifer Amsler Switzerland 7 111 0.7× 68 0.8× 90 1.3× 85 1.4× 32 0.6× 12 271
Minxi Lao China 10 83 0.5× 132 1.6× 33 0.5× 76 1.3× 22 0.4× 24 295
B. Guglielmi Italy 7 99 0.6× 206 2.6× 71 1.0× 119 2.0× 9 0.2× 10 414
Jennifer Hannah United Kingdom 6 48 0.3× 138 1.7× 60 0.8× 63 1.1× 46 0.8× 18 292
Florence Lachenal France 7 61 0.4× 91 1.1× 58 0.8× 74 1.3× 18 0.3× 21 363
Shaozhe Cai China 11 91 0.6× 117 1.5× 19 0.3× 82 1.4× 40 0.7× 28 329
Hee Sue Park South Korea 11 29 0.2× 28 0.3× 35 0.5× 37 0.6× 62 1.1× 43 291
Douglas Tremblay United States 10 71 0.4× 65 0.8× 20 0.3× 47 0.8× 16 0.3× 20 328
Ilya Kirgner Israel 10 44 0.3× 31 0.4× 13 0.2× 55 0.9× 17 0.3× 31 285
Aarat Patel United States 8 31 0.2× 158 2.0× 25 0.4× 97 1.6× 16 0.3× 16 297

Countries citing papers authored by Daniel Mrak

Since Specialization
Citations

This map shows the geographic impact of Daniel Mrak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Mrak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Mrak more than expected).

Fields of papers citing papers by Daniel Mrak

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Mrak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Mrak. The network helps show where Daniel Mrak may publish in the future.

Co-authorship network of co-authors of Daniel Mrak

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Mrak. A scholar is included among the top collaborators of Daniel Mrak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Mrak. Daniel Mrak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
2.
Kulterer, Oana C., Daniel Mrak, Irina Gessl, et al.. (2025). FAPI PET/CT for tracking disease trajectory in myositis-related interstitial lung disease. Journal of Autoimmunity. 156. 103471–103471.
3.
Karonitsch, Thomas, Roman Reindl‐Schwaighofer, Farsad Eskandary, et al.. (2025). Immunoadsorption as a novel therapy for refractory idiopathic inflammatory myopathies: a retrospective observational study. Lara D. Veeken. 64(10). 5304–5312. 1 indexed citations
4.
Gelpí, Ellen, Simon Hametner, Romana Höftberger, et al.. (2024). Impact of muscle biopsy on the clinical decision-making process in patients with suspected idiopathic inflammatory myopathy. Journal of Autoimmunity. 144. 103185–103185. 2 indexed citations
5.
Kulterer, Oana C., Elisabeth Simader, Daniel Mrak, et al.. (2024). FAPi PET/CT for assessment and visualisation of active myositis-related interstitial lung disease: a prospective observational pilot study. EClinicalMedicine. 72. 102598–102598. 7 indexed citations
6.
Vossen, Matthias G., Felix Kartnig, Daniel Mrak, et al.. (2024). Humoral and cellular response to the third COVID-19 vaccination in patients with inborn errors of immunity or mannose-binding lectin deficiency. Wiener klinische Wochenschrift. 136(21-22). 598–607.
7.
Höbaus, Clemens, et al.. (2022). Lipoprotein (a) and long-term outcome in patients with peripheral artery disease undergoing revascularization. Atherosclerosis. 363. 94–101. 8 indexed citations
8.
Bonelli, Michael, Helga Radner, Andreas Kerschbaumer, et al.. (2022). Tocilizumab in patients with new onset polymyalgia rheumatica (PMR-SPARE): a phase 2/3 randomised controlled trial. Annals of the Rheumatic Diseases. 81(6). 838–844. 61 indexed citations
9.
Mrak, Daniel, Felix Kartnig, Daniela Sieghart, et al.. (2022). Accelerated waning of immune responses to a third COVID-19 vaccination in patients with immune-mediated inflammatory diseases. Journal of Autoimmunity. 135. 102981–102981. 7 indexed citations
10.
Mandl, Péter, Selma Tobudic, Thomas Karonitsch, et al.. (2022). Response to SARS-CoV-2 vaccination in systemic autoimmune rheumatic disease depends on immunosuppressive regimen: a matched, prospective cohort study. Annals of the Rheumatic Diseases. 81(7). 1017–1022. 12 indexed citations
11.
Göschl, Lisa, Daniel Mrak, Katharina Grabmeier‐Pfistershammer, et al.. (2022). Reactogenicity and immunogenicity of the second COVID-19 vaccination in patients with inborn errors of immunity or mannan-binding lectin deficiency. Frontiers in Immunology. 13. 974987–974987. 8 indexed citations
12.
Mrak, Daniel, Michael Bonelli, & Helga Radner. (2022). Neuropsychiatric Systemic Lupus Erythematosus: A Remaining Challenge. Current Pharmaceutical Design. 28(11). 881–891. 2 indexed citations
13.
Mrak, Daniel, Selma Tobudic, Maximilian Koblischke, et al.. (2021). SARS-CoV-2 vaccination in rituximab-treated patients: B cells promote humoral immune responses in the presence of T-cell-mediated immunity. Annals of the Rheumatic Diseases. 80(10). 1345–1350. 148 indexed citations
14.
Simader, Elisabeth, Selma Tobudic, Péter Mandl, et al.. (2021). Importance of the second SARS-CoV-2 vaccination dose for achieving serological response in patients with rheumatoid arthritis and seronegative spondyloarthritis. Annals of the Rheumatic Diseases. 81(3). 416–421. 17 indexed citations
15.
Höbaus, Clemens, et al.. (2020). GlycA for long-term outcome in T2DM secondary prevention. Diabetes Research and Clinical Practice. 171. 108583–108583. 7 indexed citations
16.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jennifer Amsler Breakdown of academic impact, for papers by Minxi Lao Breakdown of academic impact, for papers by B. Guglielmi Breakdown of academic impact, for papers by Jennifer Hannah Breakdown of academic impact, for papers by Florence Lachenal Breakdown of academic impact, for papers by Shaozhe Cai Breakdown of academic impact, for papers by Hee Sue Park Breakdown of academic impact, for papers by Douglas Tremblay Breakdown of academic impact, for papers by Ilya Kirgner Breakdown of academic impact, for papers by Aarat Patel
Rankless by CCL
2026